![](https://www.Immune-System-Research.com/"wp-content/uploads"/2021/11/Avibactam-is-a-Covalent-and-Reversible-non-β-Lactamase-Inhibitor-2021-11-20.jpg)
Some Gram-negative pathogens have accumulated enough resistance mechanisms to render them virtually untreatable by modern antibacterial chemotherapy. A mainstay for…
![](https://www.Immune-System-Research.com/"wp-content/uploads"/2021/07/Relebactam-is-a-DBO-type-β-Lactamases-Inhibitor-2021-07-2.jpg)
The current epidemic of multidrug-resistant (MDR) bacterial infections is a critical challenge in health care today. A common mechanism of…
![](https://www.Immune-System-Research.com/"wp-content/uploads"/2020/01/MAC-545496-a-GraR-Inhibitor-Reverses-β-lactam-Resistance-in-MRSA-2019-01-08.jpg)
Staphylococcus aureus is a major bacterial human pathogen that causes a wide variety of clinical manifestations. Staphylococcus aureus is the…
![](https://www.Immune-System-Research.com/"wp-content/uploads"/2019/07/VNRX-5133-is-a-Potent-β-lactamase-Inhibitor-2019-07-07.jpg)
Beta-lactamases are a family of enzymes involve in bacterial resistance to β-lactam antibiotics. Beta-lactamases act by breaking the beta-lactam ring…